Refractory metastatic Crohn's disease responsive to ustekinumab dose intensification.

Xiao, Teresa L; Ezenwa, Ekene; Ruiz de Luzuriaga, Arlene; Hoffman, Mark D

Xiao, Teresa L; Ezenwa, Ekene; Ruiz de Luzuriaga, Arlene; Hoffman, Mark D.

Afiliação

Xiao TL; Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
Ezenwa E; Section of Dermatology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.
Ruiz de Luzuriaga A; Section of Dermatology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.
Hoffman MD; Section of Dermatology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

JAAD Case Rep ; 32: 65-67, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36654767

Palavras-chave

CD, Crohn's disease; MCD, Metastatic Crohn's disease; TNF, tumor necrosis factor; UST, ustekinumab; cutaneous Crohn's; drug dosing; metastatic Crohn's; skin manifestation of internal disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article